We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Report: CRO market to top $30 billion by 2018

Report: CRO market to top $30 billion by 2018

November 11, 2013
CenterWatch Staff

A new report by healthcare sector corporate finance and strategy specialist Results Healthcare says the CRO sector is seeing a recovery, driven by improved optimism across the biopharma industry, the sector’s largest customer group, where many key CRO customers are now at the tail end of multi-year patent cliffs and are stepping up investments into their pipelines, particularly products in late-stage development.

After two years of declining budgets, rising R&D expenditure and increased outsourcing—due primarily to biopharma’s need to shift fixed to variable costs and access capabilities not found internally—are expected to continue fueling steady growth of the global CRO market, which is poised to grow from $23 billion-$25 billion to over $30 billion by 2018, according to recent estimates from Bank of America Merrill Lynch.

The report, CROs and other outsourced pharmaceutical support services: M&A drivers and trends, said while M&A continues to be driven primarily by strategic buyers looking to increase scale or add specialist capabilities, they currently do not have in-house to improve their overall service offering and it is often the private equity deals that make the headlines, frequently because of their sheer scale and the impact they have on the industry.

It cites two important secondary private equity transactions completed this year, KKR’s purchase of PRA International and Research Pharmaceutical Services (RPS), as evidence of consolidation and a move to increase scale, and potentially game changing deals in the CRO sector.

“We are seeing strong appetites for acquisition in particular segments of the CRO sector,” said Hemavli Bali, executive director of Results Healthcare. “These range from medical communications and patient recruitment, to health economics and outcomes research, to patient engagement solutions, health informatics and pharmacovigilance. Healthcare IT will also remain a major focus, as CROs look to increase efficiencies across the board, including technologies that allow for real-time access to data, cloud platforms and the use of mobile devices to simplify the collection of data.”

Results Healthcare is part of Results International.

Global News CROs/Service Providers

Upcoming Events

  • 09Dec

    The Age of eSource: Modernizing Clinical Trials

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Patient-phsyician-consultation

    Giving Patients Back Their Voice in Clinical Trials

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing